Zhitong Finance App News, Kanghui Co., Ltd. (603139.SH) issued an announcement. According to the company's strategy and business development needs, the company plans to invest 35 million yuan in cash to establish a wholly-owned subsidiary, Shaanxi Kanghui Wanhuashan Pharmaceutical Co., Ltd. (“Wanhuashan Pharmaceutical”). Wanhuashan Pharmaceutical plans to have a registered capital of 35 million yuan, accounting for 100% of the registered capital, mainly engaged in drug research and development, production and sales; food, health food, cosmetics, etc.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.